One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1200/jco.2014.32.15_suppl.7093
Copy DOI Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2014 |
 Citations: 7 |
Affiliation: Johns Hopkins Medicine, Johns Hopkins University, The University of Texas MD Anderson Cancer Center, European University Viadrina, Hôpital Saint-Louis, University of California, San Francisco, University of Pennsylvania, Fred Hutch Cancer Center, Versailles Saint-Quentin-en-Yvelines University7093^ Background: For FLT3-ITD(+) AML patients (pts) who are relapsed or refractory to chemotherapy, allogeneic HSCT offers the best prospect for long-term survival. Pts are unlikely to undergo HSC...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
